The 6th Cailian Press Corporate ESG Forum concluded successfully in Beijing, where INTCO Medical stood out among numerous enterprises and received the event’s top honor — the 2025 Cailian Press Zhiyuan Award for ESG Pioneer Enterprise.

Guided by the Shanghai United Media Group and organized by Cailian Press, the forum gathered representatives from government agencies, academia, listed companies, and financial institutions to discuss ESG development and share forward-looking solutions and best practices.

Recognition from Professionals: A Continuous ESG Commitment

As a global leader in disposable gloves, INTCO Medical has been publishing ESG reports for four consecutive years since 2021. Its sustainable development efforts have earned multiple honors: in 2024, the company received the EcoVadis “COMMITTED” badge and was named one of the Top 20 ESG Listed Companies in China’s A-share Medical Device Sector. In 2025, INTCO achieved both LCA and carbon footprint certifications, was included in the S&P Global Sustainability Yearbook (China Edition) 2025, and maintained a strong Wind ESG rating of A while improving its MSCI ESG rating to BBB. The latest Zhiyuan Award further reinforces INTCO’s leadership in the ESG landscape.

Comprehensive Practice: A Blueprint for Sustainable Growth

INTCO Medical integrates ESG principles across every aspect of its operations, building a systematic framework for sustainable action.

Green Operations and Carbon Reduction

Sustainability is embedded in INTCO’s core strategy. The company has pledged to reduce carbon emissions per glove by 25% by 2030 (based on 2022 levels) and to achieve carbon neutrality in its operations by 2050. In 2024, INTCO reduced carbon emissions per glove by 20.7% year-over-year, expanded its use of renewable energy with 3.538 million kWh of solar power generation, and launched wind power infrastructure, which became operational in 2025.

Innovation and Smart Manufacturing

Driven by innovation, INTCO Medical continues to advance in medical consumables, rehabilitation equipment, and physical therapy products. In 2024, the company invested RMB 398 million in R&D, releasing 55 new products, a 197% increase compared to 2023. Through automation and AI-powered manufacturing, INTCO aims to enhance efficiency and meet the diverse needs of global customers.

Responsible Supply Chain Management

INTCO Medical has built a robust ESG-oriented supply chain system, strengthening supplier risk management and resilience. In 2024, the company organized 198 training sessions and 268 technical seminars, supporting over 1,100 suppliers with their improvement programs.

Social Responsibility and Employee Care

By the end of 2024, INTCO Medical had donated over RMB 75.82 million to social welfare causes. The company values its employees as its most important asset, fostering a culture of equality, inclusiveness, and respect. Throughout 2024, INTCO hosted employee events such as festive celebrations, afternoon tea sessions, and birthday parties, and organized 50 overseas and 8 domestic tours to enhance team engagement.

Brand Creativity: ESG Values in Action

At the forum, INTCO Medical and Cailian Press jointly launched the “Limit-Up Pioneer” co-branded gift set, which included custom-made eye masks and face masks. These items symbolized health protection and continuous growth, while also highlighting INTCO’s professional expertise in the healthcare and protective product sectors. The collaboration strengthened INTCO’s brand presence among industry and investment communities.

Winning the 2025 Cailian Press Zhiyuan Award for ESG Pioneer Enterprise marks not an endpoint, but a new beginning. INTCO Medical will continue to advance sustainability with tangible actions, leading the healthcare industry toward a greener and more responsible future.